您的位置: 首页 > 农业专利 > 详情页

Sustained release intraocular implants and methods for treating ocular vasculopathies
专利权人:
Brittany Jackson;Ton Lin;Rosy Sheng Donn;James A. Burke;Glenn T. Huang;Patrick M. Hughes;Larry A. Wheeler
发明人:
Glenn T. Huang,Brittany Jackson,James A. Burke,Ton Lin,Patrick M. Hughes,Larry A. Wheeler,Rosy Sheng Donn
申请号:
US12024010
公开号:
US09161938B2
申请日:
2008.01.31
申请国别(地区):
US
年份:
2015
代理人:
摘要:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充